Ming-chih L. Ho
National Taiwan University Hospital Hsin Chu Branch
Hsinchu, TNQ, Taiwan
Hsinchu, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Time-resolved Impact of Smoke Evacuation on Particulate Exposure During Laparoscopic Cholecystectomy.
Journal: The Journal of surgical research
Published: January 16, 2026
Less is more: A single-dose, non-waiting neoadjuvant immunotherapy strategy for hepatocellular carcinoma.
Journal: Biomedical journal
Published: January 05, 2026
The combination of ropeginterferon alfa-2b with anti-PD1 blockage in adjuvant therapy in HBV-related HCC.
Journal: Hepatology international
Published: October 05, 2025
Surgical video-based temporal action analysis algorithm and competency assessment in laparoscopic cholecystectomy: development and exploratory evaluation.
Journal: Surgical endoscopy
Published: September 03, 2025
Use of brolucizumab in refractory neovascular age-related macular degeneration: characteristics and biomarkers of intraocular inflammation from an Asian real-world study.
Journal: Japanese journal of ophthalmology
Published: July 17, 2025
Taiwan liver cancer association management consensus guidelines for intermediate-stage hepatocellular carcinoma.
Journal: Clinical and molecular hepatology
Published: July 03, 2025
Retinopathy of prematurity epidemiology and treatment trend in a tertiary medical center in Taiwan: From 2016 to 2023.
Journal: Taiwan journal of ophthalmology
Published: May 04, 2025
Minor resection for primary hepatocellular carcinoma promotes curative recurrent treatments.
Journal: Surgical oncology
Published: April 17, 2025
An integrated language-vision foundation model for conversational diagnostics and triaging in primary eye care.
Journal: Cell reports. Medicine
Published: January 27, 2025
Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial.
Journal: British journal of cancer
Published: November 11, 2024
Sequential combination with ropeginterferon alfa-2b and anti-PD-1 treatment as adjuvant therapy in HBV-related HCC: a phase 1 dose escalation trial.
Journal: Hepatology international
Published: September 20, 2024
Last Updated: 09/26/2026